| 27th Oct 2025 7:00 am |
RNS-R |
IMMUPHARMA ATTENDING BIO-EUROPE |
| 23rd Oct 2025 7:00 am |
RNS |
Launch of Website; Corporate Update |
| 13th Oct 2025 7:00 am |
RNS |
Appointment of Independent Non-Executive Director |
| 6th Oct 2025 3:22 pm |
RNS |
Holding(s) in Company |
| 17th Sep 2025 7:00 am |
RNS |
Exercise of Warrants |
| 11th Sep 2025 7:00 am |
RNS |
Exercise of Warrants |
| 1st Sep 2025 2:12 pm |
RNS |
Appointments of CSO and Head of R&D |
| 1st Sep 2025 1:20 pm |
RNS |
ImmuPharma Files New Patent Application for P140: |
| 20th Aug 2025 1:36 pm |
RNS |
Holding(s) in Company |
| 6th Aug 2025 7:00 am |
RNS |
Interim Results |
| 12th Jun 2025 12:51 pm |
RNS |
Result of AGM |
| 27th May 2025 3:13 pm |
RNS |
Holding(s) in Company |
| 20th May 2025 7:00 am |
RNS |
Notice of AGM |
| 19th May 2025 7:00 am |
RNS |
Final Results |
| 1st Apr 2025 7:00 am |
RNS |
Warrant Extension, Debt Conversion & Equity Issue |
| 1st Apr 2025 7:00 am |
RNS |
Extension of Warrants in Incanthera to 30 Sep 2025 |
| 14th Mar 2025 7:00 am |
RNS-R |
IMM attending Bio-Europe Spring 17-19 March,Milan |
| 13th Mar 2025 7:00 am |
RNS |
ImmuPharma proves unique Mechanism of Action-P140 |
| 21st Feb 2025 11:36 am |
RNS |
Holding(s) in Company |
| 13th Feb 2025 7:00 am |
RNS |
£2.91m fundraising; related party transactions |
| 28th Jan 2025 12:57 pm |
RNS |
Response to Share Price Movement |
| 9th Jan 2025 7:00 am |
RNS |
Breakthrough Findings into Autoimmune Diseases |
| 23rd Dec 2024 7:00 am |
RNS |
Change of Auditor |
| 10th Dec 2024 2:36 pm |
RNS |
Holding(s) in Company |
| 4th Dec 2024 7:00 am |
RNS |
Appointment of Company Secretary |
| 9th Sep 2024 7:01 am |
RNS |
Extension of Warrants in Incanthera to 31 Mar 2025 |
| 9th Sep 2024 7:00 am |
RNS |
Half-year Report |
| 6th Aug 2024 1:41 pm |
RNS |
Holding(s) in Company |
| 28th Jun 2024 12:17 pm |
RNS |
Result of AGM |
| 6th Jun 2024 4:20 pm |
RNS |
Holding(s) in Company |
| 5th Jun 2024 2:01 pm |
RNS |
Notice of AGM & Annual Report & Accounts |
| 5th Jun 2024 7:00 am |
RNS |
Final Results |
| 3rd Jun 2024 10:09 am |
RNS |
Realisation-c£1.5m on sale of shares in Incanthera |
| 3rd May 2024 7:00 am |
RNS |
Holding(s) in Company |
| 24th Apr 2024 7:12 am |
RNS |
IMMUPHARMA AT BIO-EQUITY 2024 12-14 May |
| 19th Apr 2024 7:00 am |
RNS |
Grant of Share Options |
| 2nd Apr 2024 7:03 am |
RNS |
New intellectual property strategy initiated |
| 25th Mar 2024 7:25 am |
RNS |
Incanthera provides Comm'l Update/Revenue F'casts |
| 19th Mar 2024 7:00 am |
RNS |
Grant of Share Options |
| 14th Mar 2024 7:00 am |
RNS |
IMMUPHARMA AT BIO-EUROPE SPRING 2024 |
